13 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
review by the FDA, Department of Justice, Department of Health and Human Services’ Office of Inspector General, state attorneys general, members
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
Services’ Office of Inspector General, state attorneys general, members of Congress, and the public. When the FDA or comparable foreign regulatory
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
, state attorneys general, members of Congress, and the public. When the FDA or comparable foreign regulatory authorities issue regulatory approval
10-Q
55iy6
12 Nov 20
Quarterly report
8:01am
424B4
7j5il6qlcoyihwtv
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
7l8fi7aqh0l0f75n 4wh
11 Sep 20
IPO registration
4:49pm
DRS/A
43o tm6hd96pgz682y
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
0iluj 94qhstwqugcqo5
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
3epv7tei
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
qjw1q
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next